In the Know
Conversations with the people and personalities in biopharma
Most Read
Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds
High blood pressure pills are costly — but also hard to find — in some lower-income countries
FDA clears Covid booster shot for healthy kids ages 5 to 11
National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials
As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver
Omitting long Covid from pandemic messaging is harmful for public health
All Coverage
advertisement